Oncotarget

Research Papers:

Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis

Daniela Loetsch, Elisabeth Steiner, Klaus Holzmann, Sabine Spiegl-Kreinecker, Christine Pirker, Juraj Hlavaty, Helga Petznek, Balazs Hegedus, Tamas Garay, Thomas Mohr, Wolfgang Sommergruber, Walter Berger _ and Michael Grusch

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2013; 4:1904-1918. https://doi.org/10.18632/oncotarget.1264

Metrics: PDF 2858 views  |   HTML 23956 views  |   ?  


Abstract

Daniela Lötsch1,2, Elisabeth Steiner1, Klaus Holzmann1, Sabine Spiegl-Kreinecker3, Christine Pirker1, Juraj Hlavaty4, Helga Petznek4, Balazs Hegedus5,6, Tamas Garay6, Thomas Mohr1, Wolfgang Sommergruber7, Michael Grusch1, Walter Berger1,2

1 Institute of Cancer Research, Department of Medicine I, Medical University Vienna, Austria;

2 Comprehensive Cancer Center-Central Nervous System Tumours Unit, Medical University of Vienna;

3 Department of Neurosurgery, Wagner-Jauregg Hospital, Linz, Austria;

4 Institute of Virology, Department of Pathobiology, University of Veterinary Medicine Vienna;

5 Division of Thoracic Surgery, Department of Surgery, Medical University of Vienna;

6 2nd Institute of Pathology, Semmelweis University, Budapest, Hungary;

7 Boehringer Ingelheim RCV GmbH & Co KG, Department of Lead Discovery, Vienna, Austria

Correspondence:

Walter Berger, email:

Keywords: major vault protein, glioblastoma multiforme, invasion, EGFR, PI3K

Received: August 8, 2013 Accepted: August 30, 2013 Published: September 1, 2013

Abstract

Despite their ubiquitous expression and high conservation during evolution, precise cellular functions of vault ribonucleoparticles, mainly built of multiple major vault protein (MVP) copies, are still enigmatic. With regard to cancer, vaults were shown to be upregulated during drug resistance development as well as malignant transformation and progression. Such in a previous study we demonstrated that human astrocytic brain tumours including glioblastoma are generally high in vault levels while MVP expression in normal brain is comparably low. However a direct contribution to the malignant phenotype in general and that of glioblastoma in particular has not been established so far. Thus we address the questions whether MVP itself has a pro-tumorigenic function in glioblastoma. Based on a large tissue collection, we re-confirm strong MVP expression in gliomas as compared to healthy brain. Further, the impact of MVP on human glioblastoma aggressiveness was analysed by using gene transfection, siRNA knock-down and dominant-negative genetic approaches. Our results demonstrate that MVP/vaults significantly support migratory and invasive competence as well as starvation resistance of glioma cells in vitro and in vivo. The enhanced aggressiveness was based on MVP-mediated stabilization of the epidermal growth factor receptor (EGFR)/phosphatidyl-inositol-3-kinase (PI3K) signalling axis. Consequently, MVP overexpression resulted in enhanced growth and brain invasion in human glioblastoma xenograft models. Our study demonstrates, for the first time, that vaults have a tumour-promoting potential by stabilizing EGFR/PI3K-mediated migration and survival pathways in human glioblastoma.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 1264